Case Study in RefractoryNon-Hodgkin’s Lymphoma: Successful Treatment with Plerixafor

Publisher： Karger

E-ISSN： 1662-6575|4|3|467-469

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.4, Iss.3, 2011-09, pp. : 467-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plerixafor and granulocyte‐colony‐stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non−Hodgkin's lymphoma: a randomized Phase 3 study

By  

TRANSFUSION, Vol. 58, Iss. 1, 2018-01 ,pp. : 81-87

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two Oral Trofosfamide Schedules in Elderly Patients with Refractory Non-Hodgkin‘s Lymphoma

By  

Oncology Research and Treatment, Vol. 22, Iss. 2, 1999-05 ,pp. : 134-138

Karger

Access to resources Recommend Favorite

Rituximab in Combination with Interferon-Alpha in Relapsed and Refractory Diffuse Large B-Cell Non-Hodgkin’s Lymphoma

By  

Acta Haematologica, Vol. 106, Iss. 3, 2001-11 ,pp. : 141-142

Karger

Access to resources Recommend Favorite

Successful Pregnancy in Stage IE Primary Non-Hodgkin’s Lymphoma of Uterine Cervix Treated with Neoadjuvant Chemotherapy and Conservative Surgery

By  

Oncology, Vol. 72, Iss. 3-4, 2008-01 ,pp. : 261-264

Karger

Access to resources Recommend Favorite

Hybrid Cytogenetics of Chronic Lymphocytic Leukemia and Follicular Cell Lymphoma in a Case of Non-Hodgkin’s Lymphoma

By  

Acta Haematologica, Vol. 116, Iss. 2, 2006-08 ,pp. : 150-152

Karger

Access to resources Recommend Favorite